Optibrium to speak about machine learning for pharma / biotech
Dr Matthew Segall from our drug discovery partner Optibrium will speak at the AI in Drug Discovery conference in London. The Alchemite™ technology from Intellegens provides the machine learning engine for Optibrium’s drug discovery solution, helping to focus experimentation and identify new candidate compounds.
